EUVIMEDEUVIMED entdecken
Crossref

Metabolic biomarkers predict subclinical cardiac remodeling in obese individuals

Mengjie Hu, Huawei Wang, Zixuan Mei, Cheng Gong, Lan Lan, Zixuan Ma, Binhao Zhang, Haomiao Fan, Yuqing Zhang, He Wang, Wanshun Chun, Dingyu Pan und 2 weitere

Metabolism and Target Organ Damage · 09.05.2026 · 6 (2)

DOI: 10.20517/mtod.2025.183 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Metabolism and Target Organ Damage, online erschienen am 09.05.2026. Verfasst von Mengjie Hu und 13 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To explore the relationship between metabolic biomarkers and cardiac remodeling indices derived from cardiac magnetic resonance (CMR) in obese adults, focusing on the role of insulin (INS) resistance and lipotoxicity in early cardiac changes.

Methods

A total of 107 obese adults undergoing preoperative metabolic evaluation were included. CMR was used to assess left ventricular (LV) structure and function. Metabolic biomarkers, including INS, free fatty acids (FFAs), triglycerides (TG), and glycated hemoglobin (HbA1c), were measured. Correlation and multivariable regression analyses were performed to examine associations between biomarkers and CMR-derived cardiac parameters. Logistic regression with receiver operating characteristic (ROC) analysis identified predictors of left ventricular hypertrophy (LVH).

Results

In this cohort of obese adults without overt hyperglycemia and with preserved ejection fraction, higher body mass index (BMI) was associated with greater left ventricular mass (LVM), volumes, and cardiac output. In multivariable models, TG (adjusted for BMI) independently predicted LVM, while a combined INS + FFAs model was a strong predictor of LVH [area under the curve (AUC) = 0.757; sensitivity = 88.7%; specificity = 37.8%; P < 0.001]. Results remained consistent when LVM was indexed to height2.7.

Conclusions

Metabolic biomarkers reflecting INS resistance and lipotoxicity are associated with early cardiac remodeling in obesity. TG captured the continuous burden of LVM, and the INS + FFAs model offered a practical metabolic prescreen for LVH risk, supporting early cardiovascular risk stratification in obese population.

Zitieren

APA

Hu, M., Wang, H., Mei, Z., Gong, C., Lan, L., Ma, Z., Zhang, B., Fan, H., Zhang, Y., Wang, H., Chun, W., Pan, D., Zhou, J., & Li, Z. (2026). Metabolic biomarkers predict subclinical cardiac remodeling in obese individuals. Metabolism and Target Organ Damage, 6(2). https://doi.org/10.20517/mtod.2025.183

Vancouver

Hu M, Wang H, Mei Z, Gong C, Lan L, Ma Z, et al. Metabolic biomarkers predict subclinical cardiac remodeling in obese individuals. Metabolism and Target Organ Damage. 2026;6(2). doi:10.20517/mtod.2025.183

BibTeX
@article{Hu2026,
  author = {Hu, Mengjie and Wang, Huawei and Mei, Zixuan and Gong, Cheng and Lan, Lan and Ma, Zixuan and Zhang, Binhao and Fan, Haomiao and Zhang, Yuqing and Wang, He and Chun, Wanshun and Pan, Dingyu and Zhou, Jianliang and Li, Zhen},
  title = {Metabolic biomarkers predict subclinical cardiac remodeling in obese individuals},
  journal = {Metabolism and Target Organ Damage},
  year = {2026},
  volume = {6},
  number = {2},
  doi = {10.20517/mtod.2025.183}
}
Kostenlos starten →